Promega corporation:1107424 - caspase GLO 3/7 assay for NIH/ncats staff anton simeonov
Ended Awarded
- Contract number
- HHSN31900002
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,910
Award facts
- Contract value 100% obligated
- $13,910.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN31900002?
HHSN31900002 was awarded to Promega Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on August 14, 2015.
How much is contract HHSN31900002 worth?
The government has obligated $13,910 on HHSN31900002.
Is contract HHSN31900002 an order under another contract?
Yes. HHSN31900002 is a BPA call under HHSN263201500038B, a blanket purchase agreement.
Was contract HHSN31900002 competed?
The extent of competition for HHSN31900002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award